Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).
- Authors
- Park, In Hae; Kim, Gun Min; Kim, Jee Hyun; Kim, Hanjo; Park, Kyong Hwa; Park, Yeon Hee; Baek, Sun Kyung; Sim, Sung Hoon; Ahn, Hee Kyung; Lee, Gyeong-Won; Lee, Kyoung Eun; Lee, Ji Eun; Lim, Seungtaek; Jung, Kyung Hae; Im, Seock-Ah
- Issue Date
- 202005
- Conference Name
- JOURNAL OF CLINICAL ONCOLOGY
- Place
- 미국
ELECTR NETWORK
- Conference Name
- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
- ISSN
- 0732-183X
1527-7755
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Park, Kyong Hwa
- Anam Hospital (Department of Medical Oncology and Hematology, Anam Hospital)